Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
Jason Willis(The University of Texas MD Anderson Cancer Center), Justin I. Odegaard(Guardant (United States)), Hyuk Lee(Yonsei University), Darya Chudova(Guardant (United States)), Richard B. Lanman(C.T. de Wit Graduate School for Production Ecology and Resource Conservation), Yoshiaki Nakamura(National Cancer Center Hospital East), Georges Azzi(Holy Cross Hospital), Stephen R. Fairclough(University of California, Berkeley), Nir Peled(Shaare Zedek Medical Center), Danielle Gavino(Olin Corporation (United States)), Jing Zhao(Anhui University), Timmy Nguyen(Cleveland Clinic Florida), Kimberly C. Banks(Guardant (United States)), Manuel Benavides(Hospital Clínico Universitario Virgen de la Victoria), Kyoung‐Mee Kim(Samsung (South Korea)), Mike Cusnir(Mount Sinai Medical Center), Marwan Fakih(City of Hope), Kabir Mody(Mayo Clinic in Florida), Takayuki Yoshino(University of Tsukuba), AmirAli Talasaz(Guardant (United States)), Martina I. Lefterova(Guardant (United States)), Ramez N. Eskander(University of California San Diego), Marcin Sikora(Guardant (United States)), Alexander Artyomenko(Guardant (United States)), Pashtoon Murtaza Kasi(Cornell University), Daniel V.T. Catenacci(University of Chicago), Victoria M. Raymond(Guardant (United States)), Jeeyun Lee(Samsung Medical Center), Jinchul Kim(Samsung Medical Center), Cátálin Bárbácioru, Seung Tae Kim(Samsung Medical Center), Scott Kopetz(The University of Texas MD Anderson Cancer Center)
Cited by 237
Related Papers
Colorectal cancer
|The Lancet|2019|5k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k